CMXC — Cell MedX Cashflow Statement
0.000.00%
Last trade - 00:00- $8.92m
- $9.97m
- $0.00m
Annual cashflow statement for Cell MedX, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.906 | -1.09 | -0.911 | -0.697 | -0.495 |
| Depreciation | |||||
| Non-Cash Items | 0.241 | 0.147 | 0.128 | 0.108 | 0.119 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.357 | 0.018 | 0.22 | 0.138 | 0.104 |
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.308 | -0.926 | -0.56 | -0.451 | -0.272 |
| Capital Expenditures | -0.002 | -0.002 | -0.002 | 0 | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.002 | -0.002 | -0.002 | 0 | — |
| Financing Cash Flow Items | 0.062 | 0.023 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.359 | 0.916 | 0.535 | 0.454 | 0.346 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.049 | -0.012 | -0.024 | 0.004 | 0.074 |